SG10201710237PA - Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance - Google Patents

Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance

Info

Publication number
SG10201710237PA
SG10201710237PA SG10201710237PA SG10201710237PA SG10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA
Authority
SG
Singapore
Prior art keywords
casein
beta
reducing
lactose intolerance
preventing symptoms
Prior art date
Application number
SG10201710237PA
Other languages
English (en)
Inventor
Andrew John Clarke
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52280344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201710237P(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of SG10201710237PA publication Critical patent/SG10201710237PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
SG10201710237PA 2013-07-12 2014-07-10 Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance SG10201710237PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361845480P 2013-07-12 2013-07-12

Publications (1)

Publication Number Publication Date
SG10201710237PA true SG10201710237PA (en) 2018-01-30

Family

ID=52280344

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201710237PA SG10201710237PA (en) 2013-07-12 2014-07-10 Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance
SG11201510707YA SG11201510707YA (en) 2013-07-12 2014-07-10 Beta-casein a2 and reducing or preventing symptoms of lactose intolerance

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201510707YA SG11201510707YA (en) 2013-07-12 2014-07-10 Beta-casein a2 and reducing or preventing symptoms of lactose intolerance

Country Status (21)

Country Link
US (3) US20160136238A1 (ko)
EP (2) EP3542805A1 (ko)
JP (2) JP6436592B2 (ko)
KR (2) KR102367941B1 (ko)
CN (3) CN110800803A (ko)
AU (2) AU2014287862B2 (ko)
BR (1) BR112016000612B8 (ko)
CA (2) CA3214545A1 (ko)
CL (1) CL2016000064A1 (ko)
DK (1) DK3019180T3 (ko)
ES (1) ES2743194T3 (ko)
HK (1) HK1223846A1 (ko)
IL (2) IL243366B (ko)
MX (2) MX368912B (ko)
MY (2) MY190309A (ko)
NZ (2) NZ754642A (ko)
PH (2) PH12016500032B1 (ko)
RU (1) RU2671562C2 (ko)
SG (2) SG10201710237PA (ko)
WO (1) WO2015005804A1 (ko)
ZA (1) ZA201600007B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2751945C9 (ru) * 2015-05-22 2021-12-21 Зе А2 Милк Компани Лимитед Бета-казеин а2 и антиоксидантная способность
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
KR102471621B1 (ko) * 2016-03-30 2022-11-25 디 에이2 밀크 컴퍼니 리미티드 베타-카세인 및 인지 기능
BR112019006336B1 (pt) * 2016-09-30 2021-09-21 The A2 Milk Company Limited Beta-caseínas e a microbiota intestinal
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442585T1 (de) 1994-11-04 2009-09-15 A2 Corp Ltd Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte
WO1996036239A1 (en) 1995-05-16 1996-11-21 Corran Norman Stuart Mclachlan Food product and process
US7094949B2 (en) * 1995-05-16 2006-08-22 A2 Corporation Limited Breeding and milking cows for milk free of β-casein A1
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
EP1196047A4 (en) * 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS
WO2002019832A1 (en) 2000-09-08 2002-03-14 New Zealand Dairy Board MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
WO2005027953A2 (en) * 2003-09-23 2005-03-31 Dsm Ip Assets B.V. Use of proline specific endoproteases to hydrolyse peptides and proteins
CN1899054A (zh) * 2006-07-17 2007-01-24 颜贻谦 去糖牛奶的制作方法
JP2012522505A (ja) * 2009-04-03 2012-09-27 ネステク ソシエテ アノニム ミルク様飲料
GB2481169B (en) * 2009-04-15 2013-08-21 Bopa Ireland Ltd A reduced lactose milk product and a process for the preparation thereof
DE102010009582A1 (de) * 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
CN103315063A (zh) * 2012-03-19 2013-09-25 基斯有限公司 可预防疾病的婴儿配方奶粉
US20170086481A1 (en) * 2014-06-03 2017-03-30 Abbott Laboratories Nutritional compositions comprising a lipophilic active ingredient

Also Published As

Publication number Publication date
BR112016000612B8 (pt) 2022-02-22
BR112016000612A2 (ko) 2017-07-25
IL261143B (en) 2021-02-28
WO2015005804A1 (en) 2015-01-15
CN114832092A (zh) 2022-08-02
AU2019203684B2 (en) 2021-08-05
ES2743194T3 (es) 2020-02-18
PH12016500032A1 (en) 2016-03-28
EP3019180B1 (en) 2019-05-29
CA2917492C (en) 2023-11-14
MX2019012446A (es) 2020-02-03
PH12016500032B1 (en) 2016-03-28
PH12019550112A1 (en) 2020-09-14
EP3542805A1 (en) 2019-09-25
JP2018203753A (ja) 2018-12-27
RU2671562C2 (ru) 2018-11-02
KR20160030974A (ko) 2016-03-21
RU2015156804A3 (ko) 2018-05-31
IL261143A (en) 2018-10-31
IL243366B (en) 2018-11-29
NZ754642A (en) 2022-09-30
HK1223846A1 (zh) 2017-08-11
JP2016523958A (ja) 2016-08-12
KR102367941B1 (ko) 2022-02-24
JP6990154B2 (ja) 2022-01-12
CN105431156A (zh) 2016-03-23
CA3214545A1 (en) 2015-01-15
AU2014287862A1 (en) 2016-02-11
BR112016000612B1 (pt) 2021-11-03
MX368912B (es) 2019-10-21
US20220175882A1 (en) 2022-06-09
CA2917492A1 (en) 2015-01-15
SG11201510707YA (en) 2016-01-28
NZ715985A (en) 2022-09-30
MY190309A (en) 2022-04-13
CN110800803A (zh) 2020-02-18
US20160136238A1 (en) 2016-05-19
EP3019180A4 (en) 2017-03-08
KR20200085375A (ko) 2020-07-14
JP6436592B2 (ja) 2018-12-12
EP3019180A1 (en) 2016-05-18
DK3019180T3 (da) 2019-08-26
KR102291660B1 (ko) 2021-08-19
AU2019203684A1 (en) 2019-06-20
AU2014287862B2 (en) 2019-07-11
RU2015156804A (ru) 2017-08-17
RU2018131604A3 (ko) 2022-04-19
MY172939A (en) 2019-12-16
RU2018131604A (ru) 2018-11-20
ZA201600007B (en) 2017-11-29
US20200147173A1 (en) 2020-05-14
CL2016000064A1 (es) 2016-12-16
MX2016000308A (es) 2016-11-14

Similar Documents

Publication Publication Date Title
IL261143B (en) Beta-casein and reduction or prevention of symptoms of lactose intolerance
HK1212582A1 (zh) 暫時閥和閥過濾器
PL2968100T3 (pl) Kombinacje amidotiazoli alkilowych i konserwantów
HK1219421A1 (zh) 激酶抑制劑的組合及其用途
IL262302B (en) Beta-casein a2 and prevention of intestinal inflammation
HK1221721A1 (zh) 蛋白抑制性的改性的二氫喹喔啉酮類化合物和二氫吡啶並吡嗪酮類化合物
SG11201509448WA (en) Creamer compositions and uses thereof
PL2801293T3 (pl) Mebel do siedzenia i okucie do niego
SG11201505342QA (en) Valve arrangement and method of operating the same
SG11201507389RA (en) Integration of hydro-dechlorination and hydro-regeneration
EP3005068A4 (en) TAP AND HOLDER
GB201320992D0 (en) Complex and uses thereof
HK1220693A1 (zh) 碳水化合物改性的糖蛋白及其用途
IL240787B (en) Mimetics of apoflavon and their uses
GB2536524B (en) Couplings and valves
ZA201601880B (en) Hetero-transglycosylase and uses thereof
RS62090B1 (sr) Cu1 soj za lečenje i/ili prevenciju hroničnog inflamatornog reumatizma
GB201319767D0 (en) Chromogenic Glucronidase Substrates and Uses
GB201308639D0 (en) Biomarkers and uses of thereof
TH1601000120A (th) เบต้า-เคซีน a2 เเละการลด หรือป้องกันอาการของการเเพ้เเลคโตส
IL227381A0 (en) A towel and a clamp
GB201301698D0 (en) Towel and method of manufacturing the same
GB201309452D0 (en) Magnetic fixings and connections
GB201301393D0 (en) Kiddibidet and pottibidet
GB201312597D0 (en) TrailerSafe reversing and safety aid